Erythropoietin

Erythropoietin (EPO) is a 165-amino-acid glycoprotein hormone — four antiparallel α-helices in the cytokine fold, ~40% of its mass N- and O-linked carbohydrate — released by the kidney's peritubular fibroblasts when tissue oxygen falls, to drive red-cell production in the marrow. This page covers the protein and its receptor; the hormone's physiology (hypoxia sensing via HIF, the feedback loop, clinical anemia use) is treated on the canonical erythropoietin hormone page. As a protein it is biotechnology's classic glycoprotein: the carbohydrate dictates half-life and activity, and the engineered ESA family (darbepoetin, peginesatide's mimic, EPO-Fc) is glycoengineering in practice.

Gene
EPO (7q22.1)
Family
Class I cytokines (four-helix bundle)
Location
Secreted; kidney source, marrow target
Structure
30.4 kDa glycoprotein; 3 N-glycans + 1 O-glycan; up-up-down-down helices
Binding Partners
EPOR (homodimeric receptor), JAK2

Structure

Function

Regulation

Interactions

Clinical Relevance

Sources